Amg-Southern Tennessee LLC
Amg-Southern Tennessee LLC was paid $9.29M by Medicaid between Jan 2018 and Dec 2024, across 168 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
WINCHESTER, TN 37398
Next to other General Practice Physician providers in Tennessee
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,136 | $115K | |
| 2019 | 5,718 | $142K | |
| 2020 | 27,930 | $775K | |
| 2021 | 55,849 | $1.59M | |
| 2022 | 95,749 | $2.03M | |
| 2023 | 127,390 | $2.36M | |
| 2024incomplete | 169,286 | $2.28M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 79,546 | 62,292 | $3.29M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 67,789 | 54,714 | $2.55M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.7% | 12,481 | 10,545 | $527K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 4.8% | 5,894 | 5,257 | $451K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.5% | 5,965 | 5,338 | $419K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.5% | 3,808 | 3,054 | $233K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 3,004 | 2,427 | $222K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.3% | 21,887 | 19,608 | $213K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 14,805 | 6,793 | $144K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 7,015 | 5,383 | $137K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.2% | 1,330 | 1,058 | $108K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,658 | 2,396 | $81K |
156 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,996 | $57K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 963 | $52K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 539 | $48K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 924 | $43K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,979 | $39K |
| 0503F | <1% | 1,056 | $35K | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 28 | $34K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,033 | $32K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 495 | $32K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 328 | $29K |
| 96160 | <1% | 4,932 | $27K | |
| 99177 | <1% | 4,983 | $26K | |
| 59025 | Fetal non-stress test | <1% | 990 | $26K |
| 59410 | <1% | 34 | $25K | |
| 96127 | <1% | 6,270 | $25K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 292 | $24K |
| 92558 | <1% | 7,159 | $24K | |
| 99381 | <1% | 332 | $24K | |
| 93000 | <1% | 4,880 | $22K | |
| 87807 | <1% | 2,194 | $21K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,578 | $21K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 260 | $20K |
| 31231 | <1% | 258 | $17K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 25 | $15K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 244 | $14K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 587 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 355 | $10K |
| 99205 | Prolong outpt/office vis | <1% | 122 | $10K |
| 81003 | <1% | 7,344 | $10K | |
| 92588 | <1% | 513 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 124 | $8K |
| 95886 | <1% | 103 | $7K | |
| 95117 | <1% | 1,324 | $6K | |
| 92557 | <1% | 368 | $6K | |
| 90715 | <1% | 187 | $5K | |
| 95911 | <1% | 66 | $5K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 93 | $5K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 69 | $5K |
| 99335 | <1% | 263 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 220 | $4K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 49 | $4K |
| 59430 | <1% | 453 | $3K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 38 | $3K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 708 | $3K |
| 92550 | <1% | 372 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 75 | $3K |
| 90697 | <1% | 1,248 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 161 | $3K |
| 90686 | <1% | 3,146 | $2K | |
| 0500F | <1% | 725 | $2K | |
| 90670 | <1% | 3,131 | $2K | |
| 90677 | <1% | 1,067 | $2K | |
| 81002 | <1% | 1,328 | $2K | |
| 96380 | <1% | 117 | $2K | |
| 93246 | <1% | 432 | $2K | |
| 90674 | <1% | 221 | $2K | |
| 3074F | <1% | 20,457 | $2K | |
| 99459 | <1% | 160 | $2K | |
| 99245 | <1% | 17 | $2K | |
| 99460 | <1% | 28 | $2K | |
| 3078F | <1% | 17,175 | $2K | |
| 3008F | <1% | 33,917 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 35 | $2K |
| 99406 | <1% | 352 | $1K | |
| 76801 | <1% | 22 | $1K | |
| 90480 | <1% | 42 | $1K | |
| 93018 | <1% | 290 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 277 | $1K |
| 99173 | <1% | 289 | $1K | |
| 52000 | <1% | 38 | $1K | |
| 3079F | <1% | 7,199 | $1K | |
| 99336 | <1% | 53 | $1K | |
| 83655 | <1% | 110 | $1K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 14 | $1K |
| 90380 | <1% | 53 | $990.00 | |
| 90756 | <1% | 133 | $979.20 | |
| 64493 | <1% | 22 | $915.26 | |
| 85018 | <1% | 350 | $870.66 | |
| 93016 | <1% | 164 | $846.48 | |
| 31575 | <1% | 18 | $771.63 | |
| 90707 | <1% | 1,326 | $760.79 | |
| 90680 | <1% | 1,477 | $755.58 | |
| 20610 | <1% | 49 | $687.01 | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 47 | $657.39 |
| 99441 | <1% | 77 | $624.18 | |
| 90716 | <1% | 1,323 | $545.51 | |
| 90473 | <1% | 43 | $542.85 | |
| 64494 | <1% | 22 | $489.49 | |
| 81025 | <1% | 115 | $478.75 | |
| 99442 | <1% | 24 | $475.84 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 27 | $465.53 |
| 94618 | <1% | 32 | $457.48 | |
| 90734 | <1% | 162 | $444.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 420 | $443.58 |
| 51798 | <1% | 176 | $398.76 | |
| 3075F | <1% | 2,858 | $383.55 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,174 | $375.48 |
| 96161 | <1% | 45 | $373.98 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 227 | $368.96 |
| 90633 | <1% | 1,365 | $309.89 | |
| 90651 | <1% | 136 | $303.62 | |
| 3077F | <1% | 1,349 | $291.84 | |
| 73562 | <1% | 17 | $286.39 | |
| 92552 | <1% | 15 | $277.02 | |
| 94664 | <1% | 54 | $276.53 | |
| 3080F | <1% | 760 | $263.64 | |
| 20611 | <1% | 17 | $254.31 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 17 | $241.71 |
| 90698 | <1% | 672 | $222.00 | |
| 64483 | <1% | 15 | $217.27 | |
| 94060 | <1% | 41 | $179.15 | |
| 99152 | <1% | 56 | $176.19 | |
| 94727 | <1% | 37 | $146.64 | |
| 90672 | <1% | 230 | $136.67 | |
| 36416 | <1% | 123 | $113.90 | |
| 94729 | <1% | 43 | $112.51 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 84 | $70.68 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 61 | $60.92 |
| 90461 | <1% | 50 | $45.04 | |
| 99454 | <1% | 53 | $39.03 | |
| G0008 | Administration of influenza virus vaccine | <1% | 87 | $38.95 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29 | $37.38 |
| 1036F | <1% | 21,210 | $21.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 13 | $20.10 |
| 1159F | <1% | 20,654 | $0.08 | |
| 1160F | <1% | 20,016 | $0.06 | |
| 1034F | <1% | 7,596 | $0.02 | |
| 3293F | 0% | 426 | $0.00 | |
| 3725F | 0% | 775 | $0.00 | |
| 0502F | 0% | 4,142 | $0.00 | |
| 3513F | 0% | 420 | $0.00 | |
| 3511F | 0% | 418 | $0.00 | |
| 90648 | 0% | 1,989 | $0.00 | |
| 3015F | 0% | 40 | $0.00 | |
| 90661 | 0% | 300 | $0.00 | |
| 90681 | 0% | 557 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 19 | $0.00 |
| 1126F | 0% | 1,909 | $0.00 | |
| 90723 | 0% | 1,462 | $0.00 | |
| 3514F | 0% | 421 | $0.00 | |
| 1035F | 0% | 1,505 | $0.00 | |
| 90696 | 0% | 132 | $0.00 | |
| 90744 | 0% | 274 | $0.00 | |
| 99024 | 0% | 1,184 | $0.00 | |
| 1125F | 0% | 4,397 | $0.00 | |
| 90620 | 0% | 72 | $0.00 | |
| 3294F | 0% | 193 | $0.00 | |
| 0501F | 0% | 246 | $0.00 | |
| 90619 | 0% | 104 | $0.00 | |
| 3292F | 0% | 407 | $0.00 | |
| 99000 | 0% | 495 | $0.00 | |
| 3512F | 0% | 424 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 72 | $0.00 |
| 90660 | 0% | 23 | $0.00 | |
| 90656 | 0% | 13 | $0.00 | |
| 90381 | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.